This is the only pure-play medical-device ETF. If you're bullish on the industry's prospects, this could be your ticket.
Device and equipment products often impose heavy customer switching costs, as practitioners are loath to transition to newer products and go through additional training.
Most of the fund's holdings have at least some semblance of a competitive advantage that preserves cash flow growth. This reduces uncertainty associated with the fair value estimates that our analysts have placed on the fund's underlying holdings. Read more